Abstract
Background: Vietnam currently imports up to 90% of the pharmaceuticals it consumes and
100% of the steroid-based pharmaceuticals. The ability for efficient chemical synthesis of the steroids
could create commercial opportunities to address this issue. Synthesis of 21-acetoxypregna-1,4,9(11)-
triene-17α,21-diol-3,20-dione is considered a key intermediate in the scheme of steroidal drug synthesis.
Previous synthesis attempts of such steroids (corticoids) introduce a double bond at C-1(2) in the final
stage of synthesis, which delivers a poor yield and reduces the economic efficiency of the process.
Objective: To study and develop a novel and effective method for the synthesis of 21-acetoxypregna-
1,4,9(11)-triene-17α,21-diol-3,20-dione.
Methods: Using 9α-hydroxyandrostenedione as a substrate chemical synthesis was performed as follows:
pregnane side chain construction at C-17 (acetylene method), introduction of C-1(2) double bond
(using SeO2), epimerization of C-17 (via 17-ONO2 ester) and Stork’s iodination.
Results: 21-acetoxypregna-1,4,9(11)-triene-17α,21-diol-3,20-dione was prepared from 9α-
hydroxyandrostenedione with an improved yield compared to previous attempts.
Conclusion: Here, 21-acetoxypregna-1,4,9(11)-triene-17α,21-diol-3,20-dione has been synthesized
from 9α-hydroxyandrostenedione based on a novel, effective and commercially feasible scheme. The
introduction of the C-1(2) double bond at an earlier stage of the synthesis has increased the economic
efficiency of the entire process. For the first time, the indirect epimerization mechanism has been clarified
along with the configuration of the C-17 stereo-center which has been confirmed using NOESY
data.
Keywords:
Phytosterols, 9α-hydroxyandrostenedione, 21-acetoxypregna-1, 4, 9(11)-triene-17α, 21-diol-3, 20-dione, steroids,
corticosteroids, NOESY.
Graphical Abstract
[1]
Nagasawa, M.; Hashiba, H.; Watanabe, N.; Tamura, M.B.; Arima, K. Microbial transformation of sterols. Part. V. Inhibitors of microbial degradation of cholesterol. Agric. Biol. Chem., 1970, 34, 838-844.
[6]
Andryushina, V.A.; Savinova, T.S.; Skryabin, K.G. Method of preparing pregnanes, RU. Patent, September 20th 2000.
[7]
Van Rheenen, V. Cyanohydrin process. U.S. Patent 4585590, February 19 1985.
[8]
Nitsuta, K. Preparation of 17α-cyanosteroid. Jpn. Patent 57062298, April 15 1982.
[11]
Sukhodol, S.G.; Savinova, T.S.; Fokina, V.V.; Shutov, A.A.; Nikolaeva, A.M.; Lukashev, N.V.; Surovtsev, V.V.; Donova, M.V. Microbiological method of producing 1,2-dehydrogenated derivatives of Δ4-3-keto-steroids of androstane family in aqueous organic media. RU Patent, 2010 9 September, 2, 447-154.
[12]
Kominek, L.A.; Wolf, H.J. Process for preparing 1,2-dehydro steroids. U.S. Patent 4524134, June 18 1985.
[13]
Weber, A.; Kennecke, M. Preparation of 3-oxo-Δ1,4-steroids. U.S. Patent 4839282 June 13 1989.
[14]
Zhao, Y.; Zhang, H. Technological process of producing betamethasone dehydrogenating material. CN. Patent, 2002 31 July, 1, 361-287.
[18]
Ercoli, A.; Gardi, R.; Brianza, C. 17-Butyrate-21-ester derivatives of 6α,9α-difluoro prednisolone, compositions and use. U.S. Patent, 1973 18 December, 3, 780-177.
[19]
Nguyen, T. Diep, Luu D. Huy, New pathway for synthesis of 21-acetoxypregna-1,4,9(11)-triene-17α,21-diol-3,20-dione. Vietnam J. Chem., 2018, 56(1), 76-80.
[20]
Luu, D. Development of novel methods to synthesis of corticoids via 17-ketosteroid intermediates. Ph.D. Thesis, Russian Academy of Sciences: Moscow. 1992.
[22]
Luu, D. Huy; Turuta, A.M.; Kamernitzky, A.V. Some experimental physical rules for the determination of the stereochemistry of the C(17)-central of the 17-X-substituted-17-ethynylsteroids. J. Ana. Sci., 2000, 5(2), 37.
[23]
Kazantsev, A.V.; Savinova, T.S.; Lukashev, N.V.; Dovbnya, D.V.; Khomutov, S.M.; Sukhodolskaya, G.V.; Shutov, A.A.; Fokina, V.V.; Nikolayeva, V.M.; Donova, M.V.; Egorova, O.V.; Surovtsev, V.V. Method of obtaining11β,17α,21-trihydroxy-16α-methyl-9α- fluoropregna-1,4-diene-3,20-dione (dexamethazone) from phytosterol. RU Patent 2532902C1 November 20 2014.